STOCK TITAN
  1. Home
  2. Sec-filings
  3. ONC
  4. [Form 4] BeOne Medicines Ltd. Insider Trading Activity

Director at BeOne Medicines (ONC) granted 18,980 restricted Ordinary Shares

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Sawyers Charles Lazelle reported acquisition or exercise transactions in this Form 4 filing.

BeOne Medicines Ltd. director Charles Lazelle Sawyers reported a grant of 18,980 Ordinary Shares as a share-based award. The award represents restricted share units that vest on the earlier of the first anniversary of the grant date or the next annual general meeting, subject to continued board service and any accelerated vesting triggers under the company’s Independent Non-Executive Director Compensation Policy. Following the award, he holds 18,984 Ordinary Shares directly. A separate entry shows 1,946 American Depositary Shares held directly, and each American Depositary Share represents 13 Ordinary Shares.

Positive

  • None.

Negative

  • None.
Insider Sawyers Charles Lazelle
Role null
Type Security Shares Price Value
Grant/Award Ordinary Shares 18,980 $0.00 --
holding American Depositary Shares -- -- --
Holdings After Transaction: Ordinary Shares — 18,984 shares (Direct, null); American Depositary Shares — 1,946 shares (Direct, null)
Footnotes (1)
  1. Represents securities underlying restricted share units. The restricted share units shall become fully vested on the earlier to occur of the first anniversary of the grant date or the date of the next annual general meeting; provided, however, that all vesting shall cease if the director resigns from the board of directors or otherwise ceases to serve as a director, unless there is a triggering event of accelerated vesting pursuant to the Company's Independent Non-Executive Director Compensation Policy. Each American Depositary Share represents 13 Ordinary Shares.
Director share award 18,980 Ordinary Shares Grant/award acquisition on 2026-06-11
Award price per share $0.0000 per share Reported grant price for 18,980 Ordinary Shares
Ordinary Shares after award 18,984 Ordinary Shares Total direct Ordinary Share holdings following transaction
ADS holdings 1,946 American Depositary Shares Direct ADS holdings reported as of 2026-06-11
ADS to Ordinary ratio 1 ADS = 13 Ordinary Shares Equity ratio stated in footnote F2
restricted share units financial
"Represents securities underlying restricted share units. The restricted share units shall become fully vested..."
Restricted share units (RSUs) are a promise from a company to give an employee or service provider actual shares or cash equal to the shares after certain conditions are met, typically staying with the company for a set time or hitting performance targets. Think of them like a time-locked gift card that becomes usable only after you’ve earned it. For investors, RSUs matter because they align employee incentives with company performance and can increase the number of shares outstanding over time, diluting existing ownership and affecting earnings per share.
Independent Non-Executive Director Compensation Policy financial
"...unless there is a triggering event of accelerated vesting pursuant to the Company's Independent Non-Executive Director Compensation Policy."
American Depositary Shares financial
"Each American Depositary Share represents 13 Ordinary Shares."
American depositary shares (ADSs) are a way for investors in the United States to buy shares of foreign companies without dealing with international markets directly. They represent ownership in a foreign company's stock and are traded on U.S. stock exchanges, making it easier for American investors to buy, sell, and own parts of companies from around the world.
grant, award, or other acquisition financial
"transaction_code_description: Grant, award, or other acquisition"
See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Form 4 Insider Transactions: What Each Field Means →
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Sawyers Charles Lazelle
(Last)(First)(Middle)
C/O BEONE MEDICINES I GMBH
AESCHENGRABEN 27, 21ST FLOOR
(Street)
BASEL4051
(City)(State)(Zip)
SWITZERLAND
(Country)		2. Issuer Name and Ticker or Trading Symbol
BeOne Medicines Ltd. [ ONC ] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
Officer (give title below)Other (specify below)
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
06/11/2026		6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Ordinary Shares(1)06/11/2026A18,980A$018,984D
American Depositary Shares(2)1,946D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Explanation of Responses:
1. Represents securities underlying restricted share units. The restricted share units shall become fully vested on the earlier to occur of the first anniversary of the grant date or the date of the next annual general meeting; provided, however, that all vesting shall cease if the director resigns from the board of directors or otherwise ceases to serve as a director, unless there is a triggering event of accelerated vesting pursuant to the Company's Independent Non-Executive Director Compensation Policy.
2. Each American Depositary Share represents 13 Ordinary Shares.
Remarks:
/s/ Qing Nian, as Attorney-in-Fact06/15/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR

FAQ

What did BeOne Medicines (ONC) director Charles Lazelle Sawyers report on this Form 4?

He reported receiving an award of 18,980 Ordinary Shares in BeOne Medicines. These are delivered as restricted share units, which are share-based compensation rather than an open-market stock purchase, and increase his direct Ordinary Share holdings to 18,984.

Is the BeOne Medicines (ONC) Form 4 transaction a stock purchase or compensation grant?

The Form 4 shows a grant or award acquisition, not a market purchase. The 18,980 Ordinary Shares are underlying restricted share units granted as director compensation, with a reported price per share of 0.0000, indicating no cash paid by the director.

How and when do the BeOne Medicines (ONC) restricted share units for Charles Sawyers vest?

The restricted share units become fully vested on the earlier of the first anniversary of the grant date or the next annual general meeting. Vesting stops if he leaves the board, unless accelerated vesting occurs under the company’s Independent Non-Executive Director Compensation Policy.

How many BeOne Medicines (ONC) shares does Charles Sawyers hold after this Form 4?

After the reported transactions, he directly holds 18,984 Ordinary Shares. In addition, a separate holding entry reports 1,946 American Depositary Shares. Each American Depositary Share represents 13 Ordinary Shares, according to the filing footnote.

What does the American Depositary Share information mean for BeOne Medicines (ONC)?

The filing states that each American Depositary Share represents 13 Ordinary Shares of BeOne Medicines. This clarifies how ADS holdings relate to underlying Ordinary Shares and helps investors understand the scale of reported ADS positions versus the company’s ordinary equity.